Sano Genetics

Sano Genetics operates a technology platform that connects and automates key workflows in precision medicine research, from study design and patient recruitment to genetic testing and longitudinal engagement. Founded in 2017 and based in Cambridge, UK, it serves pharmaceutical sponsors, contract research organizations (CROs), and research sites. The company's value proposition centers on dramatically accelerating enrollment, generating high-quality genetic and clinical data, and reducing the operational burden and cost of running complex biomarker-driven trials.

An end-to-end digital platform integrating patient recruitment, prescreening/digital consent, at-home DNA testing, electronic medical record retrieval, and longitudinal patient engagement for precision medicine research.

Competes with large, full-service CROs (e.g., IQVIA) that offer digital solutions, specialized patient recruitment firms, and other techbio platforms (e.g., Antidote, Science 37). Differentiation lies in Sano's deep integration of genetic testing and EMR retrieval with recruitment and engagement in a single, dedicated platform.